用于治疗子宫动静脉畸形的沉淀型疏水性可注射液体（PHIL）栓塞剂：技术报告
Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report.
作者信息
Kurda Dylan, Guduguntla Geetha, Maingard Julian, Kok Hong Kuan, Lalloo Shivendra
机构信息
Interventional Radiology, The Canberra Hospital, Canberra, Australia.
Interventional Radiology, Austin Health, Melbourne, VIC, Australia.
出版信息
CVIR Endovasc. 2019 May 17;2(1):17. doi: 10.1186/s42155-019-0059-z.
OBJECTIVE
Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent.
CASE REPORT
A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient's menstrual cycle was restored 8 weeks after the procedure.
CONCLUSION
Uterine AVM can be treated safely and effectively with UAE using PHIL.
目的
子宫动静脉畸形（AVM）是阴道出血的罕见原因。虽然子宫切除术是 definitive 治疗方法；但子宫动脉栓塞术（UAE）提供了另一种治疗选择。本病例展示了使用沉淀型疏水性可注射液体（PHIL）栓塞剂经导管 UAE 成功治疗子宫 AVM 的技术报告。
病例报告
一名41岁女性，孕6产4，流产2次，包括15年前的一次葡萄胎妊娠，出现大量阴道出血。盆腔超声显示后天性 AVM 是其出血的潜在病因。患者接受了双侧子宫动脉栓塞术。四周后，AVM 几乎完全消退，患者术后8周月经周期恢复。
结论
使用 PHIL 的 UAE 可安全有效地治疗子宫 AVM。
Zotero 插件